Results 221 to 230 of about 8,463 (257)

Aprepitant.

2011
openaire   +1 more source

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study

Lancet Oncology, The, 2012
Daniele Santini, Bruno Vincenzi, Anna Maria Frezza   +2 more
exaly  

Aprepitant

2016
openaire   +2 more sources

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Journal of Clinical Oncology, 2003
Richard J Gralla, Fausto Roila, Alexandra D Carides   +2 more
exaly  

Aprepitant/ifosfamide interaction

Reactions Weekly, 2021
openaire   +1 more source

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting

Cancer, 2003
Alexandra D Carides, Kevin Horgan
exaly  

Aprepitant (EMEND)

Journal Of Pain & Palliative Care Pharmacotherapy, 2005
openaire   +1 more source

Aprepitant

Drugs, 2012
exaly   +2 more sources

Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Biological Psychiatry, 2006
Guanghan F Liu, Jarmo Hietala, Martin Keller   +2 more
exaly  

Determination of solubility of Aprepitant (an antiemetic drug for chemotherapy) in supercritical carbon dioxide: Empirical and thermodynamic models

Journal of Supercritical Fluids, 2017
Gholamhossein Sodeifian, Seyed Ali Sajadian   +1 more
exaly